Fast recovery of cardiac function in PIMS-TS patients early using intravenous anti-IL-1 treatment-Reference-Cited by-同舟云学术

Fast recovery of cardiac function in PIMS-TS patients early using intravenous anti-IL-1 treatment

Published:2021-04-07 Issue:1 Volume:25 Page:
ISSN:1364-8535
Container-title:Critical Care
language:en
Short-container-title:Crit Care

Author:

Mastrolia Maria Vincenza^ORCID,Marrani Edoardo,Calabri Giovanni Battista,L’Erario Manuela,Maccora Ilaria,Favilli Silvia,Duchini Pier Paolo,Pagnini Ilaria,Simonini Gabriele

Publisher

Springer Science and Business Media LLC

Subject

Critical Care and Intensive Care Medicine

Link

http://link.springer.com/content/pdf/10.1186/s13054-021-03548-y.pdf

Reference6 articles.

1. Kooistra EJ, Waalders NJB, Grondman I, Janssen NAF, de Nooijer AH, Netea MG, et al. Anakinra treatment in critically ill COVID-19 patients: a prospective cohort study. Crit Care. 2020;24(1):688.

2. Belhadjer Z, Méot M, Bajolle F, Khraiche D, Legendre A, Abakka S, et al. Acute heart failure in multisystem inflammatory syndrome in children in the context of global SARS-CoV-2 pandemic. Circulation. 2020;142(5):429–36.

3. Belhadjer Z, Auriau J, Méot M, Oualha M, Renolleau S, Houyel L, et al. Addition of corticosteroids to immunoglobulins is associated with recovery of cardiac function in multi-inflammatory syndrome in children. Circulation. 2020;142(23):2282–4.

4. Evans C, Davies P. SARS-CoV-2 paediatric inflammatory syndrome. Paediatr Child Health. 2021;31(3):110–5.

5. Ramcharan T, Nolan O, Lai CY, Prabhu N, Krishnamurthy R, Richter AG, et al. Paediatric inflammatory multisystem syndrome: temporally associated with SARS-CoV-2 (PIMS-TS): cardiac features, management and short-term outcomes at a UK Tertiary Paediatric Hospital. Pediatr Cardiol. 2020;41(7):1391–401.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact Of Anakinra Use On Clinical Outcomes In Children With Moderate Or Severe Multisystem Inflammatory Syndrome In Children: A Propensity Score Matched Retrospective Cohort Study;2023-09-26

2. A meta analysis on the utility of Anakinra in severe COVID-19 disease;Cytokine;2023-09

3. Early anakinra treatment improves cardiac outcome of multisystem inflammatory syndrome in children, regardless of disease severity;Rheumatology;2023-08-30

4. Outcomes of MIS-C patients treated with anakinra: a retrospective multicenter national study;Frontiers in Pediatrics;2023-08-22

5. Clinical outcomes and safety of anakinra in the treatment of multisystem inflammatory syndrome in children: a single center observational study;Pediatric Rheumatology;2023-07-31